Omnia Biologics is a custom Contract Manufacturing Organization that offers contract services for biotechnology and pharmaceutical companies in process development, cGMP manufacture, and fill-finish for preclinical and Phase I/II clinical programs of novel therapeutics having significant manufacturing challenges. These products include vaccines, autologous therapeutics, new gene therapeutic platforms, and stem cell technologies. The company seeks and has established relationships with both biopharmaceutical companies and academic investigators throughout the world.